cilostazol has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypothermia has been reported to induce ventricular tachycardia and fibrillation (VT/VF) in patients with early repolarization (ER) pattern." | 5.40 | Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. ( Antzelevitch, C; Gurabi, Z; Koncz, I; Nesterenko, VV; Patocskai, B, 2014) |
| "Hypothermia has been reported to induce ventricular tachycardia and fibrillation (VT/VF) in patients with early repolarization (ER) pattern." | 1.40 | Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. ( Antzelevitch, C; Gurabi, Z; Koncz, I; Nesterenko, VV; Patocskai, B, 2014) |
| "Cilostazol was discontinued, and shortly thereafter the ventricular tachycardia subsided." | 1.31 | Rapid ventricular tachycardias associated with cilostazol use. ( Gamssari, F; Garcia, E; Ho, JS; Liu, B; Mahmood, H; Massumi, A; Rasekh, A; Villareal, RP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K | 1 |
| Miyazaki, S | 1 |
| Ishikawa, E | 1 |
| Mukai, M | 1 |
| Aoyama, D | 1 |
| Nodera, M | 1 |
| Kaseno, K | 1 |
| Tada, H | 1 |
| Gurabi, Z | 2 |
| Koncz, I | 2 |
| Patocskai, B | 2 |
| Nesterenko, VV | 1 |
| Antzelevitch, C | 2 |
| Barajas-Martinez, H | 1 |
| Hu, D | 1 |
| Gamssari, F | 1 |
| Mahmood, H | 1 |
| Ho, JS | 1 |
| Villareal, RP | 1 |
| Liu, B | 1 |
| Rasekh, A | 1 |
| Garcia, E | 1 |
| Massumi, A | 1 |
4 other studies available for cilostazol and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
Topics: Ablation Techniques; Action Potentials; Anti-Arrhythmia Agents; Cilostazol; Defibrillators, Implanta | 2019 |
Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cilostazol; Disease Models, Animal; Dogs; Electr | 2014 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud | 2016 |
Rapid ventricular tachycardias associated with cilostazol use.
Topics: Aged; Aged, 80 and over; Cilostazol; Female; Humans; Intermittent Claudication; Phosphodiesterase In | 2002 |